Osstem Implant, which will be delisted on the 14th, will be purchased on the market at 1.9 million won per share until the 11th

Reporter Kim Jisun / approved : 2023-08-03 05:59:00
  • -
  • +
  • 인쇄
오스템임플란트 (사진=연합뉴스)

 

[Alpha Biz=(Chicago) Reporter Kim Jisun] Dentistry Investment, the largest shareholder of Osstem Implant, which will be voluntarily delisted on the 14th, will buy shares of small investors.

According to the industry on the 3rd, Dentistry Investment, the largest shareholder of Osstem Implant, is scheduled to sell from this day to the 11th (7 business days). Osstem Implant will be delisted from the KOSDAQ market on the 14th, the business day after the closing sale period.

Dentistry Investment will purchase 1.9 million won per share to protect small investors during the clearance period. Dentistry Investment also plans to make over-the-counter purchases for stocks that have not been purchased during the period at the same price for six months after the delisting of Osstem Implant.

Dental Investment, which holds 90.1% of the shares issued by Ostem Implant through two public purchases, holds a 96.2% stake in Ostem Implant Chairman Choi Kyu-ok, a co-holder under the KOSDAQ Listing Regulations, and can buy the remaining 3.8% (60,925 shares) from small investors. The amount of money needed to buy stocks is about 115.8 billion won.

The Korea Exchange finally approved the application for voluntary delisting of Osstem Implant after deliberation by the Corporate Review Committee on the 1st.

Osstem Implant, which was listed on the KOSDAQ market on February 7, 2007, will be converted from a listed company to an unlisted company after 16 years and 6 months of listing.

 

Alphabiz Reporter Kim Jisun(stockmk2020@alphabiz.co.kr)

주요기사

Civic Groups File Complaint Against Baemin and Coupang Eats Over Alleged Misleading “One-Person Free Delivery” Promotions2025.09.19
KT Confirms Additional Victims in Unauthorized Micro-Payment Case, Faces Criticism Over Initial Response2025.09.19
KFTC Grants Conditional Approval for Joint Venture Between Shinsegae Group and Alibaba Group2025.09.19
Supreme Court Rules in Favor of NTS on U.S. Unregistered Patent Royalties2025.09.19
Korea Zinc to Cancel All Treasury Shares by Year-End, Targeting Shareholder Return Ratio Above 200%2025.09.19
뉴스댓글 >

HEADLINE

건강이 보이는 대표 K Medical 뉴스

PHOTO

많이 본 기사